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Experimental Studies of Esophageal Cancer 
1. Production and Observation of an Experimental Model 
of Esophageal Cancer by V x2 Carcinoma 
NoBuo SAITO 
The 2nd Department of Surgery, Faculty of Medicine, Kyoto University 
(Director: Prof. Dr. YORINORI HIKASA) 
The treatment of esophageal cancer has made less progress toward reducing that cancer 
than the treatment of cancers of other digestive organs. The disparity in the progress of treat-
ment is due to the unique anatomical location of the esophagus over neck, thorax, and abdomen, 
and .the great variety of tumor growth and metastasis. In the face of these two problems it 
becomes necessary to observe the growth of the tumor in the wall of the esophagus. 
Vx2 carcinoma was implanted in the wall of the esophagus of rabbits. They were dissected 
at intervals of several days. The proliferation and metastasis of the carcinoma were histologically 
observed, and the following results were obtained. 
Based on the obtained results, the author concludes there are several possibilities of thera-
peutic applications in addition to clinical application in this cancer model. 
1. Tumor proliferation 
a Vertical extent increases when compared to previous days. 
b Depth of invasion reaches the next layer we巴kly,but it has no tendency to reach th巴
superficial layer. 
c 100% ulcerlation occurs within 16 days in every case subsequent to implantation in the 
submucosa, and the proliferation is always found on the margin of the ulcer. 
2. Organ metastasis 
Key words: V×2 carcinoma, Esophageal cancer model, Cancer metastasis, Esophageal cancer, Growth of the 
tumor. 
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a Organ metastases are first observed within 21 days from implantation and are 100% 
complete within 30 days. 
b Organ metastases are found in 100% of lungs, 385ぢoflivers, 23. 8% of kidneys, and in 
lesser percentages in the adrenal gland, thyroid gland, myocardium, stomach, and dia-
phragm. 
c Location of tumors makes no difference in organ metastasis, but abdominal esophageal 
tumor seems to cause liver metastasis, compared with other parts of the esophagus. 
d Organ metastases are not found in the case of less than 20 mm of vertical extent and 
ao depth of invasion. 
3. Lymph node metastasis 
a Lymph node metastases are first found within 10 days from implantation, and are 100% 
complete within 16 days. 
b The number of metastatic lymph nodes increases rapidly after 3 weeks. 
c Lymph node metastases are detected in almost every case of more than 15 mm of vertical 
extent. 
d Up to 3 weeks, tumors of the abdominal esophagus have higher density of lymph node 
metastases. After 3 weeks_, the density of lymph node metastases tends to be higher as 
the location of the tumors on the esophagus becomes lower. 
e Tumors of the cervical esophagus metastasize to cervical and thoracic lymph nodes at 
almost the same rate. 
f Tumors of the upper thoracic esophagus metastasize to thoracic lymph nodes at first, 
subsequently to cervical and at last to abdominal. 
g Tumors of the lower thoracic esophagus metastasize to thoracic lymph nodes at first, 
subsequently to abdominal, and at last to cervical lymph nodes. 
h Tumors of the abdominal eso五hagusmetastasize to abdominal and lower thoracic lymph 
















































































































＼＼＼部＼位＼＼＼日＼｜！ っー 弓ロ同 10~14 
頚部（Ce)
。 4 
上胸部（Ju) 1 1 (1) 
下胸部（lm-Ei)I 2 10 
腹部（Ea) 2 2 (2) 






14日で 16.1mm, 16～17日で 19.2 mm, 21日で 24.1 
mm, 24～26日で 25.3mm, 28臼で 35.9mm, 30～35 
日で 46.8mmとなる．経目的IC直線的増大を示し，











16 21 24-28 計
4 5 1 14 
(1) (1) 
5 3 13 
(1) (1) (6) 
5 26 
(2) (1) (3) 
3 2 1 10 
(2) 
17 17 7 63 
(1) (3) (5) (12) 
）死亡例
は sm1例， pm3例， a12例， a.1例.2～3週では
sm, pm IL止まる例はなく a,3例， a24例.4週では
pm 1例， a11例， a.以上6f?IJであった.30日以上で
は全例旬以上であった．
粘膜下へ移植された腫蕩の粘膜面への発育をみる為
























ぶ式 3-7 10-14 16-21 24-28 35-37 
a，↑ ． ．． ． ． 
a, ． ． ． 
Pm ．。 ． 
Sm 0000 。






















iζ示した．深遠度 smでは平均長径 4.5mm, pmで
は 14mm,a1では 16.3 mm, a2では 27.9mmとな
る
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Ce j 5 ｜肺（2川 28,3凡肺肝腎（28)
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group 1 lζ含まれ，逆に group1の727ぢが2.0以下の
値となる.3週以後の例lζ限ると group1の78%が2.0 
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Zeidman仙.，は Brown-Pearcecarcinoma, Walker 肺転移の易形成性が示唆された．
=1 le:= 
腫湯増殖との関係は，長径 20mm 以下の例には臓
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